BEIJING HOTGEN BIOTECH financial statements, including revenue, expenses, profit, and loss
The total revenue of 688068 for the last quarter is 134.23 M CNY, and it's 35.76% higher compared to the previous quarter. The net income of Q4 23 is -16.77 M CNY.